據3月20日的歐盟官方公報消息,由于眾多物質的再評價涉及的風險評估等及其他工作仍在進行或由于無法保證在到期日之前對最終評審結果做出決定,因此歐盟委員會對以下28個在法規(EC) No 1107/2009下批準的活性物質(原批準到期日為2023年4月30日)期限進行延長,其中絕大部分是在2022年已延續過的有效成分。
本次獲批準延長的物質詳見下表:
序號 | 有效成分名稱 | 現批準有效期 |
1 | 福美鋅 Ziram | 15 March 2025 |
2 | 嘧菌胺 Mepanipyrim | 15 March 2025 |
3 | 炔草酯 Clodinafop | 15 December 2025 |
4 | 抗蚜威 Pirimicarb | 15 March 2025 |
5 | 砜嘧磺隆 Rimsulfuron | 15 August 2025 |
6 | 滅菌唑 Triticonazole | 15 March 2025 |
7 | 嘧菌環胺 Cyprodinil | 15 March 2025 |
8 | 乙膦酸 Fosetyl | 15 March 2025 |
9 | 抗倒酯 Trinexapac | 15 December 2024 |
10 | 滴丙酸 Dichlorprop-P | 15 March 2025 |
11 | 葉菌唑 Metconazole | 15 March 2025 |
12 | 嘧霉胺 Pyrimethanil | 15 March 2025 |
13 | 三氯吡氧乙酸Triclopyr | 15 December 2024 |
14 | 苯菌酮Metrafenone | 15 December 2024 |
15 | 枯草芽孢桿菌菌株QST 713 Bacillus subtilis (Cohn 1872) strain QST 713 | 15 August 2024 |
16 | 多殺菌素 Spinosad | 15 March 2025 |
17 | 蘇云金芽胞桿菌鲇澤亞種菌株ABTS-1857,菌株GC-91 Bacillus thuringiensis subsp. aizawai strain ABTS-1857 and strain GC-91 | 15 August 2024 |
18 | 蘇云金芽孢桿菌以色列亞種H14菌株AM 65-52 Bacillus thuringiensis subsp. israeliensis (serotype H-14) strain AM65-52 | 15 August 2024 |
19 | 蘇云金芽孢桿菌庫斯塔克亞種菌株ABTS-351,菌株PB54, SA11, SA12 和EG2348 Bacillus thuringiensis subsp. kurstaki strain ABTS 351, strain PB 54, strain SA 11, strain SA 12, strain EG 2348 | 15 August 2024 |
20 | 球孢白僵菌菌株ATCC 74040 ,菌株GHA Beauveria bassiana strain ATCC 74040, strain GHA | 30 September 2025 |
21 | Cydia pomonella Granulovirus (CpGV) | 15 August 2024 |
22 | 深綠木霉菌株T11 Trichoderma atroviride (formerly T. harzianum) strain T11 | 15 April 2025 |
23 | 哈茨木霉菌株T-22和ITEM 908 (Trichoderma harzianum strain T-22, strain ITEM 908 | 15 April 2025 |
24 | 棘孢木霉菌株ICC012,菌株T25,菌株TV1 Trichoderma asperellum (formerly T. harzianum) strain ICC012, strain T25, strain TV1 | 15 April 2025 |
25 | 蓋姆斯木霉菌株ICC080 Trichoderma gamsii (formerly T. viride) strain ICC080 | 15 April 2025 |
26 | 唑螨酯 Fenpyroximate | 15 June 2026 |
27 | 馬拉硫磷Malathion | 31 July 2026 |
28 | 噠螨靈 Pyridaben | 31 July 2026 |
詳見下方公告鏈接:
瑞旭集團農化事業部將持續跟蹤并更新農藥活性物質在加拿大,EPA,歐盟,印度等的的批準狀態,禁限用情況等信息,想了解更多海外登記資訊,歡迎聯系我們。
相關推薦: